Who is sponsoring NCT04313946?

NCT04313946 is sponsored by Professor Adrian Covic.

What drugs are being tested in NCT04313946?

Interventions in NCT04313946: Scanning Chest X-rays and performing AI algorithms on images.

What condition does NCT04313946 study?

NCT04313946 studies COVID-19, Pneumonia, Viral, Influenza With Pneumonia, Flu Symptom, Flu Like Illness, Pneumonia, Interstitial, Pneumonia, Ventilator-Associated, Pneumonia Atypical.

Is NCT04313946 still recruiting?

NCT04313946 is currently status unknown. Last updated 27 April 2020.

Last reviewed 2020-04-27 · How we verify

NCT04313946: AI-COVID-Xr

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays

Status unknown Last updated 27 April 2020

What this trial tests

trial testing Scanning Chest X-rays and performing AI algorithms on images in COVID-19 in 200 participants. Status unknown.

Timeline

18 March 2020

Primary endpoint
16 August 2020

18 August 2020

Quick facts

Lead sponsor	Professor Adrian Covic
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	18 March 2020
Primary completion	16 August 2020
Estimated completion	18 August 2020
Sites	3 locations across Italy, Romania, United Kingdom

Drugs / interventions tested

Scanning Chest X-rays and performing AI algorithms on images

Conditions studied

COVID-19 — all drugs for COVID-19 →
Pneumonia, Viral — all drugs for Pneumonia, Viral →
Influenza With Pneumonia — all drugs for Influenza With Pneumonia →
Flu Symptom — all drugs for Flu Symptom →

Sponsor

Professor Adrian Covic

Who can join

Eligibility, any sex, with COVID-19 or Pneumonia, Viral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to use artificial intelligence (image discrimination) algorithms, specifically convolutional neural networks (CNNs) for scanning chest radiographs in the emergency department (triage) in patients with suspected respiratory symptoms (fever, cough, myalgia) of coronavirus infection COVID 19. The objective is to create and validate a software solution that discriminates on the basis of the chest x-ray between Covid-19 pneumonitis and influenza

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
Tahmasebi S, Khosh E, Esmaeilzadeh A. · · 2020 · cited 29× · PMID 32452050 · DOI 10.1002/jcp.29804
SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments.
Wang X, Li J, Liu H, Hu X, et al · · 2023 · cited 7× · PMID 36985154 · DOI 10.3390/microorganisms11030580
Curbing the AI-induced enthusiasm in diagnosing COVID-19 on chest X-Rays: the present and the near-future
Burlacu A, Crisan-Dabija R, Popa IV, Artene B, et al · · 2020 · DOI 10.1101/2020.04.28.20082776

Verify or expand the search:

Other trials of Scanning Chest X-rays and performing AI algorithms on images

Trials testing the same drug.

NCT04996381 — Feasibility of AI-based Heart Function Prediction Model Using CXR · completed

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Professor Adrian Covic trials

Trials by the same sponsor.

NCT04325867 — Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 · NA · unknown
NCT03393065 — Lung Ultrasound Guided Protocol for Fluid Management for the Critically Ill Patient: a Randomized Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04313946 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Professor Adrian Covic
Last refreshed: 27 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04313946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing